Skip to main content
medical-deviceiec-62443gmppharma

Predictive Maintenance for Medical-Device Manufacturing (IEC 62443 SL-1)

Prevly Team·

Predictive Maintenance for Medical-Device Manufacturing (IEC 62443 SL-1)

Predictive maintenance pitches usually lead with uptime and cost savings. In medical-device and pharmaceutical manufacturing, those come after a different gate: will the IT-security and quality teams allow this tool onto the network at all?

These plants run validated processes under quality-management systems and OT-security frameworks. A PdM tool that ignores that reality never gets past the first review — no matter how good its models are. So this post is about the requirements that come before the ROI conversation.

The buyer you have to satisfy first

In a regulated plant, a PdM purchase touches at least three stakeholders, and the order they evaluate in matters:

  1. OT / IT security — "Can this tool touch our control systems? What's its attack surface? Does it phone home?"
  2. Quality / validation — "Does it handle regulated data correctly? Is there an audit trail? Will it complicate our validated state?"
  3. Maintenance / reliability — "Does it actually predict failures we care about, and can we trust the predictions?"

Most vendors are built to win conversation #3 and improvise on #1 and #2. In medical-device manufacturing, you have to clear #1 and #2 first.

IEC 62443: the framework that decides

IEC 62443 is the international standard for industrial automation and control-system security. It defines Security Levels (SL-1 through SL-4) and seven Foundational Requirements (FR1–FR7): identification & authentication, use control, system integrity, data confidentiality, restricted data flow, timely response to events, and resource availability.

A monitoring tool aligned to SL-1 maps to those requirements with concrete, checkable controls. Prevly publishes an IEC 62443-3-3 SL-1 conformance statement, and the design choices behind it are exactly the ones a reviewer probes:

| Foundational Requirement | How a read-only on-prem monitor answers it | |---|---| | FR1 Identification & authentication | Integrates with the plant identity provider; no shared or vendor-cloud accounts. | | FR2 Use control | Role-based access; the monitoring credential is read-only on the control system. | | FR3 System integrity | No write path into the control system; signed, versioned deployments. | | FR4 Data confidentiality | On-premise storage; tenant isolation; no PHI ingested. | | FR5 Restricted data flow | No required outbound egress; data stays inside the plant boundary. | | FR6 Timely response to events | Audit logging of system events. | | FR7 Resource availability | Passive monitoring; the tool can't starve or disrupt the control system. |

The detail that surprises people: a predictive maintenance tool for machines doesn't need patient data. It ingests vibration, temperature, pressure, current — equipment telemetry. No PHI, no patient records, nothing that pulls it into the highest-sensitivity data class. That single fact removes an enormous amount of review friction, and it should be stated explicitly in any meddev PdM evaluation.

Why read-only and on-prem aren't optional here

Two architecture choices do most of the work in a regulated environment:

  • Read-only OT access. Condition monitoring should add zero ways to change machine behavior. A read-only OPC-UA subscription observes; it never writes a tag or calls a method. The worst case if the monitor is compromised is read access to values the historian already exposes — not control. (We cover this in depth in our read-only OPC-UA post.)
  • On-premise deployment. Data residency, no outbound egress, and an auditor who can see everything on-site are far easier to satisfy when the analytical brain runs inside the plant. On-prem is also the market norm, not the exception — Grand View Research (2025) puts the on-premise segment at 57.3% of the PdM market, citing control, security, and data privacy.

Together these turn the security review from a list of findings into a short conversation.

Fitting into a validated / GMP environment

A point worth being precise about: a PdM tool does not make you compliant, and no honest vendor claims it does. Compliance is a property of your validated processes and quality system. What a well-designed tool does is fit inside that system without creating new problems:

  • Audit trail. System events and maintenance actions are logged, so the tool's activity is accountable rather than opaque.
  • Versioned, reproducible deployment. A validated environment needs to know exactly what's running; a signed, versioned deployment supports that.
  • Predictable data handling. You know what data the tool holds, where, and that it isn't reaching outside the boundary — which is what your data-flow documentation has to show.
  • Explainable predictions. In a GMP context, "the model said so" isn't a defensible basis for action. Per-feature attribution on every prediction gives the documented reasoning a quality system expects.

We deliberately avoid the regulatory-clearance and compliance-promise language some vendors reach for — a tool cannot grant those. What it can do is be built so that adopting it doesn't jeopardize a state you've already validated. That's the realistic, and honest, claim.

The evaluation checklist for a regulated plant

  1. Is there an IEC 62443 conformance statement we can read?
  2. Does it ingest any PHI or patient data? (For machine monitoring, the answer should be no.)
  3. Is OT access strictly read-only — in code, not just configuration?
  4. Can it run on-premise with no required outbound egress?
  5. Does it produce an audit trail and explainable predictions our quality team can document?
  6. Will the vendor support our validation effort with architecture and data-flow documentation?

A vendor who can answer these crisply has already done the hard part. The uptime and cost-savings conversation — the one most vendors lead with — is the easy part that comes after.


Prevly is an on-premise predictive maintenance platform aligned to IEC 62443-3-3 SL-1, built for medical-device and pharma manufacturing: read-only OPC-UA, no PHI, on-site ML, and an audit trail that fits a validated environment. Read the architecture or request a technical walkthrough.

Related reading: Pharma GMP predictive maintenance (Annex 1 / GAMP 5 / Part 11) · GDPR & industrial IoT compliance · On-premise vs cloud PdM · Read-only OPC-UA monitoring